12 research outputs found

    Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.

    Get PDF
    BACKGROUND: Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD 2017 provides a comprehensive assessment of cause-specific mortality for 282 causes in 195 countries and territories from 1980 to 2017. METHODS: The causes of death database is composed of vital registration (VR), verbal autopsy (VA), registry, survey, police, and surveillance data. GBD 2017 added ten VA studies, 127 country-years of VR data, 502 cancer-registry country-years, and an additional surveillance country-year. Expansions of the GBD cause of death hierarchy resulted in 18 additional causes estimated for GBD 2017. Newly available data led to subnational estimates for five additional countries-Ethiopia, Iran, New Zealand, Norway, and Russia. Deaths assigned International Classification of Diseases (ICD) codes for non-specific, implausible, or intermediate causes of death were reassigned to underlying causes by redistribution algorithms that were incorporated into uncertainty estimation. We used statistical modelling tools developed for GBD, including the Cause of Death Ensemble model (CODEm), to generate cause fractions and cause-specific death rates for each location, year, age, and sex. Instead of using UN estimates as in previous versions, GBD 2017 independently estimated population size and fertility rate for all locations. Years of life lost (YLLs) were then calculated as the sum of each death multiplied by the standard life expectancy at each age. All rates reported here are age-standardised

    A common mutation, R208X, identified in Vietnamese patients with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency

    No full text
    Mitochondrial acetoacetyl-CoA thiolase (12) deficiency is an inborn error of metabolism affecting isoleucine catabolism and ketone body utilization. This disorder is clinically characterized by intermittent keto-acidotic episodes with no clinical symptoms between episodes. In general, 12 gene mutations are heterogenous. No common mutations have been identified and more than 70 mutations have been identified in 70 patients with 12 deficiency (including unpublished data). We herein identified a common mutation, R208X, in Vietnamese patients. We identified R208X homozygously in six patients and heterozygously in two patients among eight Vietnamese patients. This R208X mutation was also identified heterozygously in two Dutch patients, however, R208X mutant alleles in the Vietnamese have a different haplotype from that in the Dutch, when analyzed using Msp I and Tag I polymorphisms in the T2 gene. The R208X mutant allele was not so frequent in the Vietnamese since we could not find that mutant allele in 400 healthy Vietnamese controls using the Nla III restriction enzyme assay. DNA diagnosis of 12 deficiency may be applicable to the Vietnamese population. (C) 2010 Elsevier Inc. All rights reserved

    Numerical study of agglomerate abrasion in a tumbling mixer

    No full text
    A numerical simulation using the Discrete Element Method (DEM) was performed to investigate the phenomena concerning the abrasion and breakage of agglomerates in a diffusion powder mixer. Agglomerates were created by defining a single structure of particles with bonds of different strengths using the Bonded Particle Model (BPM). By comparing the agglomerate size reduction calculated by intact and broken bonds with that agglomerate size calculated by particle number, it was possible to differentiate abrasion and breakage behavior of the agglomerate in the system. The DEM simulations gave support to earlier investigations which concluded that definition of a Stoke abrasion number is a valid approach to predict agglomerate abrasion in a powder blending system. (C) 2014 Elsevier Ltd. All rights reserved

    Inflammatory and growth factor response to continuous and intermittent exercise in youth with cystic fibrosis

    Get PDF
    Background: Children with cystic fibrosis (CF) tend to suffer from chronic systemic inflammation and may have impaired growth associated with muscle catabolism. Therefore, investigating which type of exercise can elicit an anabolic response with minimal inflammation is of clinical value. Methods: Twelve children with CF (mean +/- SD; age: 14.7 +/- 2.3 years, predicted FEV1: 90.0 +/- 21.6%) and biological age-matched controls (age: 13.9 +/- 2.1 years) completed moderate-intensity, continuous exercise (MICE) and high-intensity, intermittent exercise (HIIE) on separate days. During each exercise, blood was drawn at various time points and analyzed for immune cells, inflammatory cytokines, and growth mediators. Results: At rest, children with CF had higher concentrations of neutrophils and IL-6 compared with controls. In children with CF, HUE did not affect immune cell subsets or cytokines: TNF-alpha, IL-6, and tumor necrosis factor-like weak inducer of apoptosis (TWEAK). All immune cell subsets and IL-6 increased significantly with MICE in both groups. Growth hormone (GH) increased with both types of exercise, with a greater change from rest during MICE. Conclusions: HIIE was a sufficient stimulus to increase OH in children with CF, without affecting systemic inflammation. (C) 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved

    Global impact of the COVID-19 pandemic on stroke care and intravenous thrombolysis

    No full text

    Global impact of the COVID-19 pandemic on stroke care and intravenous thrombolysis

    No full text

    Global impact of the COVID-19 pandemic on stroke care and intravenous thrombolysis

    No full text

    Global impact of the COVID-19 pandemic on stroke care and intravenous thrombolysis

    No full text
    corecore